IAVI

0 followers


Translating scientific discoveries into affordable, globally accessible public health solutions.


IAVI is a non-profit that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases.

Headquarters

New York, US

Employees

201-500

Links

Org chart

Mark Feinberg
President and CEO

Mark Feinberg

Collapse
Ana Céspedes
Chief Operating Officer
Sree Chitoor
Chief Technology Officer
Dagna Laufer
Vice President And Head Of Clinical Development
Eric Skjeveland
Vice President, Head Of Business Development And Alliance Management
Jon Heinrichs
Vice President, Antibody Program Strategy And Translational Immunology
Mario Gagliano
Vice President, Human Resources & Chief People Officer
Marion Gruber
Vice President, Public Health And Regulatory Science
Swati Gupta
Vice President And Head Of Emerging Infectious Diseases And Epidemiology
Kundai Chinyenze
Advance Chief Of Party And IAVI Africa Director
Polet Juma
Leads The Financial And Operational Functions In Iavi’s Kenya Country Office And The Regional Programs In Africa.
George Amemba
Director - Risk, Audit & Compliance
Karen Chandler Cain
Director, Financial Operations (contracts And Partnerships)
Gaby Chaiban
Associate Director - Financial Planning And Analysis
Fundiswa Moyo
Snr Manager: Financials And Office Operations